If you liked this article you might like

Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
European Markets Mixed, Auto Stocks Slide, U.S. Dollar Slumps
AstraZeneca Gets 'Complete Response Letter' From FDA on Hyperkalaemia Treatment